The American Society for Radiation Oncology issued an updated clinical guideline on the use of radiation therapy to treat patients with brain metastases, with the goal of supporting the multidisciplinary planning and delivery of advanced radiation therapy techniques to manage intact and resected brain metastases from non-hematologic solid tumors.
Deaths from uterine cancer are rising in the U.S., and are highest among non-Hispanic Black women, according to a new study led by researchers at NCI. The higher death rates are related to the rising incidence of aggressive subtypes of uterine cancer.
Two studies led by researchers at the American Cancer Society showed an increase in the use of proton beam therapy for patients with cancer in the U.S. during the past decade.
A study led by researchers at ACS showed cancer survivors in the United States who reported medical financial hardship have a higher mortality risk than cancer survivors without financial hardship. Medical financial hardship was measured as problems affording health care or delaying or forgoing any health care due to cost in the past 12 months.
Findings led by researchers at the American Cancer Society show that five-year survivors of adolescent and young adult cancer in the United States have a higher risk of developing and nearly double the risk of dying from a new primary cancer as the general population.
Access to therapies approved over the last decade has significantly lengthened median survival times in patients with metastatic hormone-sensitive prostate cancer, according to a large randomized clinical trial conducted by researchers from SWOG Cancer Research Network.
The American Society of Clinical Oncology published new guidelines to support clinicians in managing immune-related adverse events in adult cancer patients treated with CAR T-cell therapy.
Researchers from the Gwangju Institute of Science and Technology have developed a deep learning model that predicts unexpected drug-drug interactions (DDIs) based on their effects on gene expression.
Breast cancer screening and early detection efforts have contributed to improved survival in recent decades, as breast cancer is more easily treated at early stages. But not all women have benefited equally.
A phase Ib study by MD Anderson researchers demonstrated that targeting angiogenesis drivers—such as delta-like ligand 4 (DLL4)—may improve responses to vascular endothelial growth factor (VEGF) inhibitors and may lead to improved outcomes in patients with platinum-resistant ovarian cancer (PROC).